A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)

Journal article

Open access

Peer reviewed

J.-M. Nabholtz, K. Al Saleh, A. Bounedjar, H. Abdel-Razeq, H. Errihani, A. Saadeddin, M. Al Foheidi, M. Ghosn, H. El Zawahry, A. Kandil, …

Annals of oncology, Vol.29, pp.viii85-viii85

10/2018

PMID: 32138097

Files and links (1)

url

https://doi.org/10.1093/annonc/mdy270.227View

Published (Version of record) Open

1 Record Views

Title: A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)
Creators - without role: J.-M. Nabholtz - King Saud University
K. Al Saleh - King Saud University
A. Bounedjar - University of Blida
H. Abdel-Razeq - King Hussein Cancer Center
H. Errihani - Institut National d'Oncologie
A. Saadeddin - National Guard Health Affairs
M. Al Foheidi - National Guard Health Affairs
M. Ghosn - Saint Joseph University
H. El Zawahry - Medical Oncology, National Cancer Institute (NCI)/ Cairo, Cairo, Egypt
A. Kandil - Alexandria University
N. Abdel-Aziz - King Saud University
F. Dabouz - Data Management
S. Kullab - King Saud University
Publication Details: Annals of oncology, Vol.29, pp.viii85-viii85
Publisher: Elsevier Ltd
Identifiers: 9920608908331
Academic Unit: King Abdulaziz University; King Saud University
Language: English
Resource Type: Journal article